Data from French named patient program of quizartinib in relapsed/refractory acute myeloid leukemia. Issue 7 (7th June 2021)

• Record Type: Journal Article
• Authors: Fodil, S.; Raffoux, E.; Dumas, P. Y.; Desbrosses, Y.; Larosa, F.; Chantepie, S.; Larcher, M. V.; Mear, J. B.; Peterlin, P.; Hunault-Berger, M.; Hospital, M. A.; Morel, V.; Lucas, N.; Vidal, V.; Salanoubat, C.; Michel, J.; Mediavilla, C.; Ojeda-Uribe, M.; Alexis, M.; Frayfer, J.; Carré, M.; Maillard, N.; Redjoul, R.; Banos, A.; Detrait, M.; Cluzeau, T.; Wickenhauser, S.; Chaoui, D.; Elassy, M.; Pigneux, A.; Dombret, H.; Récher, C.; Bertoli, S.;
• Is Part Of: Leukemia & lymphoma. Volume 62:Issue 7(2021)
• Page Start: 1756
• Page End: 1760
• Publication Date: 2021-06-07
• Subjects: Leukemia -- Periodicals; Lymphomas -- Periodicals; 616.99419
• DOI: 10.1080/10428194.2021.1881505
• Languages: English
• ISSNs: 1042-8194